Fixed drug eruption (FDE): changing scenario of incriminating drugs
- 28 July 2006
- journal article
- review article
- Published by Wiley in International Journal of Dermatology
- Vol. 45 (8), 897-908
- https://doi.org/10.1111/j.1365-4632.2006.02853.x
Abstract
No abstract availableThis publication has 110 references indexed in Scilit:
- Specific site involvement in fixed drug eruptionJournal of the American Academy of Dermatology, 2003
- Fixed drug eruption to three anticonvulsant drugs: An unusual case of polysensitivityJournal of the American Academy of Dermatology, 1997
- Hypersensitivity to paclitaxel manifested as a bullous fixed drugeruptionJournal of the American Academy of Dermatology, 1996
- Genetic susceptibility to fixed drug eruption: Evidence for a link with HLA-B22Journal of the American Academy of Dermatology, 1994
- Fixed drug eruption caused by diphenhydramineJournal of the American Academy of Dermatology, 1993
- Transient, nonpigmenting fixed drug eruption caused by radiopaque contrast mediaJournal of the American Academy of Dermatology, 1990
- Fixed drug eruption due to dimenhydrinateJournal of the American Academy of Dermatology, 1989
- Wandering fixed drug eruption: A mucocutaneous reaction to acetaminophenJournal of the American Academy of Dermatology, 1987
- Nonpigmenting fixed drug eruption as a distinctive reaction pattern: Examples caused by sensitivity to pseudoephedrine hydrochloride and tetrahydrozolineJournal of the American Academy of Dermatology, 1987
- Fixed drug eruption due to minocycline—report of one caseJournal of the American Academy of Dermatology, 1983